Cabaser (cabergoline): Reviews and patient testimonials
Back to the list of medications
Medication indications
Cabaser 1 mg Tablets
Treatment of Parkinson's disease
If treatment with a dopamine agonist is being considered, cabergoline is indicated as second line therapy in patients who are intolerant or fail treatment with a non-ergot compound, as monotherapy, or as adjunctive treatment to levodopa plus dopa-decarboxylase inhibitor, in the management of the signs and symptoms of Parkinson's disease. Treatment should be initiated under specialist supervision. The benefit of continued treatment should be regularly reassessed taking into account the risk of fibrotic reactions and valvulopathy (see sections 4.3, 4.4 & 4.8).Cabaser Tablets 2 mg
Treatment of Parkinson's disease
If treatment with a dopamine agonist is being considered, cabergoline is indicated as second line therapy in patients who are intolerant or fail treatment with a non-ergot compound, as monotherapy, or as adjunctive treatment to levodopa plus dopa-decarboxylase inhibitor, in the management of the signs and symptoms of Parkinson's disease. Treatment should be initiated under specialist supervision. The benefit of continued treatment should be regularly reassessed taking into account the risk of fibrotic reactions and valvulopathy (see sections 4.3, 4.4 & 4.8).Route of administration: Oral
Molecule: cabergoline
Patients' opinions on Cabaser
Conditions related to this medication
Fact sheet
See the fact sheet
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.